alexa In-vivo Therapeutic Potential Of Biologically Synthesized Silver Nanoparticles
ISSN: 2376-0419

Journal of Pharmaceutical Care & Health Systems
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

10TH Asia-Pacific Pharma Congress
May 08-10, 2017 Singapore

Kalakotla Shanker and Gottumukkala Krishna Mohan
JNT University Hyderabad, India
ScientificTracks Abstracts: J Pharma Care Health Sys
DOI: 10.4172/2376-0419-C1-020
Abstract
In recent times, nanomaterials are being used in antidiabetic studies for their exclusive properties such as small size, more surface area, biocompatibility and enhanced solubility. In view of this, present study aimed to evaluate the antihyperglycemic potential of Biologically Synthesized Silver Nanoparticles (BSSNPs) and Gymnema Sylvestre (GS) extract. The crystalline nature of the BSSNPs was confirmed by x-ray diffraction; the characteristic peaks observed at 2θ = 38.23º, 44.33º, 64.56º and 77.45º were corresponded to (111), (200), (220) and (311). The SEM and HRTEM analysis divulges that the BSSNPs were spherical in shape. EDAX spectrum exhibits peaks for the presence of silver, carbon and oxygen atoms in the range of 1.0-3.1 keV. The results showed increased blood glucose, cholesterol, triglycerides, LDL, VLDL, huge loss in body weight, downturn in plasma insulin. The GS extract (200 mg/kg, 400 mg/kg), BSSNPs (200 mg/kg, 400 mg/kg) and Metformin 50 mg/kg were administered to the diabetic rats. BSSNPs at dose level of 400 mg/kg showed significant inhibition of blood glucose levels and lipid profile as compared with GS extract treated group. These detections revealed that BSSNPs possess potent antihyperglycemic and anti-hyperlipidemic activity and thus preferable over crude extract.
Biography

Kalakotla Shanker has completed MPharm from JNT University Hyderabad and he is currently pursuing 3rd year of full time PhD in JNT University Hyderabad, India. He has published more than 15 research papers in international peer reviewed reputed journals.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords